Data regarding the hematologic manifestations of COVID-19 infection are emerging. Patients with severe disease may have higher total white cell counts (Table 7) (median 6100 cells/mm3).20 , 21 Otherwise, similar to the other novel coronavirus infections, lymphopenia is a frequent finding, is present in a third of patients.21 , 121 Hence, lymphopenia may help as a reference index.121 However, there may not be any differences in lymphocyte counts between mild and severe forms of COVID-19. Neutrophilia may help to predict ICU admissions. Hemoglobin seems to be mostly unaffected by COVID-19 infection. DIC is a rare complication.21 In general, mild thrombocytopenia is present in one-third of patients.21 Patients requiring ICU admissions are seen to have higher levels of D-dimer.14 A meta-analysis of 9 studies showed significantly higher PT and d-dimer levels in patients with more severe disease, indicating the likelihood of DIC or a highly inflammatory state.56 The incidence of thromboembolic events in these patients is garnering a lot of attention. A study conducted by Llitjos et al found a 69% incidence of thromboembolic events, with a 56% incidence even in patients treated with therapeutic anticoagulation.57 Increased levels of circulatory cytokines, ferritin, C-reactive protein and procalcitonin also seem to correlate with the severity of the disease.34 , 58